miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis
Background and aims: Systemic sclerosis (SSc) is a common autoimmune disorder involving the skin, blood vessels, and internal organs with an elusive pathophysiology. SSc is believed to be a genetically prone T-cell-mediated autoimmune disease. miRNAs and lncRNAs were thought to be involved in the et...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2024-03-01
|
Series: | Non-coding RNA Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468054023000951 |
_version_ | 1797267196969222144 |
---|---|
author | Ahmed MB. Khedr Olfat G. Shaker Mohamed HM. EL-Komy Amul M. Badr Randa Erfan |
author_facet | Ahmed MB. Khedr Olfat G. Shaker Mohamed HM. EL-Komy Amul M. Badr Randa Erfan |
author_sort | Ahmed MB. Khedr |
collection | DOAJ |
description | Background and aims: Systemic sclerosis (SSc) is a common autoimmune disorder involving the skin, blood vessels, and internal organs with an elusive pathophysiology. SSc is believed to be a genetically prone T-cell-mediated autoimmune disease. miRNAs and lncRNAs were thought to be involved in the etiology of several immunological diseases including SSc. This work aimed to assess the expression of miRNA-133, lncRNA-H19, PKM2, and TGF-β levels in SSc in comparison to controls and their relationship to the clinical course and severity of disease. Patients and methods: Fifty patients with SSc and 40 healthy age and sex-matched controls were included in this study. miRNA-133 and H19 expression levels were detected using quantitative RT-PCR while serum levels of PKM2 and TGF-β were measured using ELISA techniques. Patients’ clinical data and treatments received were extracted and correlated with proteins investigated. Results: Our results showed that miRNA-133 was significantly downregulated in SSc patients in comparison to controls (Mean + SD of SSc = 0.61 ± 0.22, Mean ± SD of HC = 0.97 ± 0.007, p = 0.003). However, there was significant upregulation of the serum expressions of all other tested biomarkers in SSc patients in comparison to controls; H19 (Mean + SD of SSc = 10.37 ± 3.13, Mean ± SD of HC = 1.01 ± 0.01, p = 0.0001), PKM2 (Mean + SD of SSc = 28.0 ± 4.84, Mean ± SD of HC = 16.19 ± 1.32, p = 0.005) and TGF-β (Mean + SD of SSc = 150.8 ± 6.36, Mean ± SD of HC = 23.83 ± 0.93, p = 0.0001). We also detected several correlations between serum levels of the investigated proteins in patients with SSc. Conclusion: Along with TGF-β, our results show that miRNA-133, H19, and PKM2 seem to be potential contributors to SSc pathogenesis and could be promising biomarkers in the diagnosis of SSc patients. The lncRNA-H19 correlations with TGF- β, miRNA-133, and PKM2 suggest a possible influential effect of this RNA molecule on the pathogenesis of SSc. |
first_indexed | 2024-03-08T19:58:24Z |
format | Article |
id | doaj.art-a3a9edbc1cd040bb94d73aa660d9c469 |
institution | Directory Open Access Journal |
issn | 2468-0540 |
language | English |
last_indexed | 2024-04-25T01:12:45Z |
publishDate | 2024-03-01 |
publisher | KeAi Communications Co., Ltd. |
record_format | Article |
series | Non-coding RNA Research |
spelling | doaj.art-a3a9edbc1cd040bb94d73aa660d9c4692024-03-10T05:12:31ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402024-03-0191253261miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosisAhmed MB. Khedr0Olfat G. Shaker1Mohamed HM. EL-Komy2Amul M. Badr3Randa Erfan4Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Helwan University, Ain Helwan, Cairo, Egypt; Corresponding author.Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, EgyptDermatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, EgyptBackground and aims: Systemic sclerosis (SSc) is a common autoimmune disorder involving the skin, blood vessels, and internal organs with an elusive pathophysiology. SSc is believed to be a genetically prone T-cell-mediated autoimmune disease. miRNAs and lncRNAs were thought to be involved in the etiology of several immunological diseases including SSc. This work aimed to assess the expression of miRNA-133, lncRNA-H19, PKM2, and TGF-β levels in SSc in comparison to controls and their relationship to the clinical course and severity of disease. Patients and methods: Fifty patients with SSc and 40 healthy age and sex-matched controls were included in this study. miRNA-133 and H19 expression levels were detected using quantitative RT-PCR while serum levels of PKM2 and TGF-β were measured using ELISA techniques. Patients’ clinical data and treatments received were extracted and correlated with proteins investigated. Results: Our results showed that miRNA-133 was significantly downregulated in SSc patients in comparison to controls (Mean + SD of SSc = 0.61 ± 0.22, Mean ± SD of HC = 0.97 ± 0.007, p = 0.003). However, there was significant upregulation of the serum expressions of all other tested biomarkers in SSc patients in comparison to controls; H19 (Mean + SD of SSc = 10.37 ± 3.13, Mean ± SD of HC = 1.01 ± 0.01, p = 0.0001), PKM2 (Mean + SD of SSc = 28.0 ± 4.84, Mean ± SD of HC = 16.19 ± 1.32, p = 0.005) and TGF-β (Mean + SD of SSc = 150.8 ± 6.36, Mean ± SD of HC = 23.83 ± 0.93, p = 0.0001). We also detected several correlations between serum levels of the investigated proteins in patients with SSc. Conclusion: Along with TGF-β, our results show that miRNA-133, H19, and PKM2 seem to be potential contributors to SSc pathogenesis and could be promising biomarkers in the diagnosis of SSc patients. The lncRNA-H19 correlations with TGF- β, miRNA-133, and PKM2 suggest a possible influential effect of this RNA molecule on the pathogenesis of SSc.http://www.sciencedirect.com/science/article/pii/S2468054023000951Systemic sclerosismiRNA-133lncRNA H19PKM2TGF-β |
spellingShingle | Ahmed MB. Khedr Olfat G. Shaker Mohamed HM. EL-Komy Amul M. Badr Randa Erfan miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis Non-coding RNA Research Systemic sclerosis miRNA-133 lncRNA H19 PKM2 TGF-β |
title | miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis |
title_full | miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis |
title_fullStr | miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis |
title_full_unstemmed | miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis |
title_short | miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis |
title_sort | mirna 133 and lncrna h19 expressions and their relation to serum levels of pkm2 and tgf β in patients with systemic sclerosis |
topic | Systemic sclerosis miRNA-133 lncRNA H19 PKM2 TGF-β |
url | http://www.sciencedirect.com/science/article/pii/S2468054023000951 |
work_keys_str_mv | AT ahmedmbkhedr mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis AT olfatgshaker mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis AT mohamedhmelkomy mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis AT amulmbadr mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis AT randaerfan mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis |